U.S. Telecom Services and Carriers Stock News

If you are wondering whether Maximus shares are now offering value or still look fully priced, the recent share performance gives you some useful clues. The stock last closed at US$69.11, with returns of 2.2% over 1 year but declines of 6.3% over 7 days, 7.5% over 30 days, and 20.1% year to date. Recent headlines have focused on Maximus as a key contractor in government services, including ongoing work in areas such as health and human services administration. This keeps attention on the...

Burlington Stores (BURL) is back in focus after releasing fourth quarter and full year results, sharing new earnings guidance, and outlining fresh store expansion plans that together reshaped expectations around the stock. See our latest analysis for Burlington Stores. The latest update around earnings, guidance and store expansion comes after a 90 day share price return of 10.9% and a 1 year total shareholder return of 22.84%. This suggests momentum has been firm over the medium term, even...

Wondering if Globe Life at around US$137.62 is pricing in too much optimism or too much caution? This article walks through what that share price could imply about value. The stock has seen mixed recent returns, with a 2.4% decline over the last 7 days and a 4.6% decline over the last 30 days, while still showing 8.9% over 1 year, 31.9% over 3 years and 48.5% over 5 years. These moves are playing out against a backdrop of ongoing attention on US insurers, including Globe Life, as investors...

Stryker (NYSE:SYK) CEO Kevin Lobo has been appointed to GE HealthCare's Board of Directors. The appointment adds medical technology, operational, and financial leadership experience to GE HealthCare's board. The move highlights Stryker's presence within the wider healthcare equipment and services sector. Stryker, a major player in medical technology and surgical equipment, sits at the crossroads of hospital capital spending, procedure volumes, and long term healthcare demand. Kevin Lobo's...

Investors may be wondering whether HP's current share price reflects its true worth, or if the recent weakness is setting up an opportunity. HP shares closed at US$18.22, with returns of a 1.3% decline over 7 days, 5.4% decline over 30 days, 17.6% decline year to date, 33.4% decline over 1 year, 26.3% decline over 3 years and 25.8% decline over 5 years. This performance may have changed how the market views its risk and reward profile. Recent headlines around HP have largely focused on how...

Q4 results put Builders FirstSource under pressure Builders FirstSource (BLDR) is back in focus after a difficult Q4 2025, where weaker housing demand and reduced operating leverage weighed on net sales, net income, and recent share performance. See our latest analysis for Builders FirstSource. That difficult quarter has fed into weaker momentum, with a 30 day share price return of 24.5% and a 1 year total shareholder return of 32.5%. However, the 5 year total shareholder return of 104.4%...

If you are wondering whether CorMedix at around US$6.37 is a bargain or a value trap, the next sections are going to focus squarely on what the numbers suggest about its current price. The stock has seen sharp swings, with a 4.8% decline over the last week, a 13.2% decline over the last month, a 47.6% decline year to date, a 41.9% decline over the past year, but a 97.8% gain over three years that still leaves five year returns at a 26.8% decline. These moves have put valuation firmly in...

McRae Industries (OTCPK:MCRA.A) has just posted Q2 2026 results with revenue of US$27.9 million and basic EPS of US$0.42, set against a trailing twelve month picture of US$117.8 million in revenue and EPS of US$3.14 that reflects earnings growth of 16.1% per year over the past five years. Over recent quarters, revenue has ranged between US$27.5 million and US$31.2 million while quarterly EPS has moved between US$0.42 and US$1.40. This leaves investors to weigh a trailing net margin of 6%...

Madison Square Garden Entertainment Corp. and Sphere Entertainment Co. recently appointed Allen Lo, a veteran technology and media lawyer, as Executive Vice President and Chief Legal Officer for both companies, where he will oversee all corporate and business legal affairs and support senior leadership on major transactions and governance. Lo’s background leading complex legal, intellectual property, and regulatory matters at Meta, Google, and Juniper Networks may prove important as Sphere...

Cimpress recently deepened its relationship with CloudLab, fully integrating the technology provider into the Cimpress family while retaining CloudLab’s CEO Marc Horriar and CTO Ionut Berescu to steer its product roadmap and innovation efforts. This equity alliance is designed to accelerate development of Cimpress’ technology stack while preserving CloudLab’s independence, potentially enriching Cimpress’ mass-customization capabilities and product offering breadth. Next, we’ll examine how...

MP Materials (MP) stock is back in focus after recent conference presentations outlined government backed rare earth plans, a large Texas magnet project, and expanded supply deals with major technology and auto customers. See our latest analysis for MP Materials. Despite recent conference updates on government backed support and the Texas magnet build out, the latest 1 day share price return of a 3% decline and 7 day share price return of a 7.6% decline contrast with a much stronger 1 year...

In March 2026, SharkNinja, Inc. launched the Shark ChillPill, a US$149.99, 3‑in‑1 personal cooling device featuring a bladeless fan, evaporative mister, and contact cooling plate, initially available exclusively on Amazon.com with broader retail rollout from March 11, 2026. At the same time, Artisan Small Cap Fund exited its multiyear position in SharkNinja purely on valuation discipline, even while recognizing the company’s ongoing innovation‑driven profit cycles and product...

Comcast, NasdaqGS:CMCSA, has launched AI Grid collaborations with NVIDIA, Decart, and Personal AI to bring real time AI processing to the network edge. The company is trialling new use cases such as hyper personalized advertising, AI driven business concierge agents, and ultra low latency streaming and gaming. Comcast is also expanding its multi gigabit fiber network into Miami Dade County coastal communities, extending high speed connectivity to more homes and businesses. Comcast enters...

Recent performance context for Nutanix (NTNX) Nutanix (NTNX) has seen mixed share performance recently, with gains over the past week contrasting with weaker moves over the past month and past 3 months. This has prompted investors to reassess what the current pricing implies. See our latest analysis for Nutanix. At a share price of $41.47, Nutanix’s recent 8.45% 7-day share price return contrasts with its 18.04% year-to-date share price decline and a 43.07% 1-year total shareholder return...

Revolution Medicines recently announced that nine oral and poster presentations highlighting advances across its RAS(ON) inhibitor pipeline were featured at the 2026 AACR Annual Meeting in San Diego, including new Phase 1 data for zoldonrasib in KRAS G12D mutant non-small cell lung cancer and Phase 1/2 data for daraxonrasib in first line metastatic pancreatic ductal adenocarcinoma. The company also showcased preclinical research on a new class of mutant-targeted catalytic RAS(ON) inhibitors...

Adeia Inc. recently announced that it expanded and renewed its intellectual property licensing relationship with United Microelectronics Corporation and signed a new multi-year semiconductor IP license agreement with Advanced Micro Devices that also settled all outstanding litigation between the two companies. These deals deepen Adeia’s links with major chipmakers while extending access to its hybrid bonding and 3D integration technologies, potentially enhancing the resilience and breadth of...

Institutional interest and board changes put Kilroy Realty in focus Recent market attention on Kilroy Realty (KRC) has been shaped by Bamco Inc. NY taking a new position in the stock and the appointment of Gary Stevenson as chair of the board. See our latest analysis for Kilroy Realty. At a share price of $29.26, Kilroy Realty has seen a 2.7% 7 day share price return, a 30 day share price return of 7.8%, and a year to date share price return of 23%, while the 3 year total shareholder return...

NRG Energy (NYSE:NRG) has partnered with Equilibrium Energy to deploy the AI native PowerOS platform for portfolio optimization. This is the first public application of PowerOS within NRG’s operations. The rollout is aimed at bringing enterprise level AI tools into NRG’s decision making and operational processes. NRG Energy, trading at $159.11, has seen a very large 3 year return and a 1 year return of 63.9%, with a 7.1% gain over the past week. Recent Simply Wall St coverage has focused on...

Shareholders at NYSE:NVR have filed multiple proposals ahead of the upcoming annual meeting. The proposals seek enhanced disclosure of greenhouse gas emissions and stronger shareholder rights to call special meetings. NVR’s board has recommended voting against both items, putting governance and sustainability practices under closer investor scrutiny. NVR, which last closed at $6,482.82, is coming into the meeting with a mixed recent track record, including a 19.5% return over 3 years and...

Doximity recently released a report showing that 94% of U.S. physicians are either using or interested in adopting AI in clinical practice, highlighting growing integration across both clinical and administrative workflows. The study also found that while physicians see AI as a way to cut administrative burden and free up more time with patients, 71% remain concerned about its accuracy and reliability, underscoring a tension between enthusiasm and caution. We’ll now examine how this surge in...

Lantheus Holdings (LNTH) shares are in focus after the FDA approved PYLARIFY TruVu, a new formulation of its PSMA PET imaging agent for prostate cancer, highlighting potential implications for manufacturing efficiency and product reach. See our latest analysis for Lantheus Holdings. The FDA approval of PYLARIFY TruVu arrives alongside a 30 day share price return of 15.65% and a 90 day share price return of 23.75%, yet the 1 year total shareholder return is a 22.31% decline, indicating that...

In March 2026, Uranium Energy Corp. reported second-quarter results showing sales of US$20.2 million, down from US$49.75 million a year earlier, with a net loss of US$13.94 million and basic loss per share from continuing operations of US$0.03 versus US$0.02 previously. Over the six months to January 31, 2026, sales dropped to US$20.2 million from US$66.84 million, yet the net loss narrowed to US$24.28 million from US$30.39 million, implying that while revenue weakened, the company limited...

Wondering if Janus Henderson Group at around US$51.36 is still offering value or if most of the opportunity is already priced in? This article focuses on what the numbers say about the stock. The share price has recently closed at US$51.36, with returns of 1.6% over 7 days, 4.7% over 30 days, 7.5% year to date and 40.1% over 1 year, while the 3 year and 5 year returns sit at 131.2% and 114.3%. Recent coverage around Janus Henderson Group has centered on its role in the Capital Markets...

Olema Pharmaceuticals, Inc. recently reported fourth-quarter 2025 results showing a US$46.06 million net loss and a US$162.45 million full-year net loss, alongside a new US$71.82 million shelf registration for common stock tied to an ESOP-related offering. Despite widening annual losses, the company slightly narrowed its per-share loss, highlighted a US$505.4 million cash position, and continued to advance its breast cancer pipeline with new clinical trials and planned scientific...